KANGPU BIOPHARMACEUTICALS, LTD.
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
KANGPU BIOPHARMACEUTICALS, LTD.
Social Links:
Industry:
Biopharma Clinical Trials Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.kangpugroup.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
52.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS IIS
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Bioheng
Bioheng is a high-tech R&D innovation company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Nagoya Institute of Clinical Pharmacology
Nagoya Institute of Clinical Pharmacology is a professional service company.
QnQuality Pharmaceuticals
QnQuality Pharmaceuticals is a drug R&D company.
Current Employees Featured
Founder
Investors List
Shining Capital
Shining Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Zhongguancun Kaiyuan Capital
Zhongguancun Kaiyuan Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Lapam Capital
Lapam Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Yijing Capital
Yijing Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
ABC International
ABC International investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Ruihe Venture Capital
Ruihe Venture Capital investment in Series B - Kangpu Biopharmaceuticals, Ltd.
Furong Capital
Furong Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Shenzhen Guozhong Venture Capital Management
Shenzhen Guozhong Venture Capital Management investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Kangpu Biopharmaceuticals, Ltd.
Official Site Inspections
http://www.kangpugroup.com
- Host name: ecs-119-3-105-187.compute.hwclouds-dns.com
- IP address: 119.3.105.187
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "Kangpu Biopharmaceuticals, Ltd."
Company Profile-Kangpu Biopharmaceuticals - kangpugroup.com
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of autoimmune diseases, …See details»
Leadership-Kangpu Biopharmaceuticals
Dr. Ge has over 20 years of global pharmaceutical industry experience and has held leading roles in drug discovery and development. Prior to founding Kangpu, Dr. Ge has worked at various US-based biotech and pharmaceutical …See details»
Kangpu Biopharmaceuticals, Ltd. - Crunchbase …
Contact Email [email protected] Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed …See details»
Kangpu Biopharmaceuticals, Ltd. | LinkedIn
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of solid tumors, hematological …See details»
Kangpu Biopharmaceuticals Profile and History - Datanyze
Www.kangpugroup.com Kangpu Biopharmaceuticals Profile and History Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and …See details»
Kangpu Biopharmaceuticals - PitchBook
Kangpu Biopharmaceuticals General Information Description. Opeartor of a clinical-stage company intended to focus on the discovery and development of medical drug candidates …See details»
Kangpu Biopharmaceuticals - Overview, News & Similar
Mar 19, 2023 Who is Kangpu Biopharmaceuticals. Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for …See details»
Kangpu - Company Profile - Tracxn
Aug 3, 2024 Kangpu - Developer of small molecule drugs to treat cancer, auto-immune, and inflammatory disease. Raised a total funding of $38.9M over 1 round from 8 investors. …See details»
Kangpu Biopharmaceuticals Ltd. (康朴生物医药技术（上海）有限 …
了解Kangpu Biopharmaceuticals Ltd. (康朴生物医药技术（上海）有限公司)公司的药物管线，治疗领域，技术平台，以及它的5项临床试验, 64篇新闻和2篇文献，疾病领域:肿瘤，免疫系统疾 …See details»
Kangpu Completes Patient Enrollment for Phase IIa Clinical
For more information, please visit www.KangpuGroup.com. Forward-Looking Statements. The statement(s) made in this press release describing Kangpu’s predictions, expectations and …See details»
Kangpu Completes Patient Enrollment for Phase IIa Clinical Trial of …
Mar 20, 2023 For more information, please visit www.KangpuGroup.com. Forward-Looking Statements. The statement(s) made in this press release describing Kangpu's predictions, …See details»
Kangpu Announces First Patient Dosed in the US Phase IIa Clinical …
Jun 13, 2022 For more information, please visit www.KangpuGroup.com. Forward Looking Statements. The statement(s) made in this press release describing Kangpu's predictions, …See details»
公司介绍-康朴生物医药官网 - KangpuGroup.com
安徽省合肥市包河区四川路868号云谷创新园B区B1栋4层401室. 邮箱: [email protected]See details»
Kangpu Announces First Patient Dosed in the US Phase IIa Clinical …
SHANGHAI, June 13, 2022 /PRNewswire/ — Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced today that the first patient has been dosed in …See details»
About-Kangpu Biopharmaceuticals - KangpuGroup.com
Kangpu Biopharmaceuticals, Ltd. is a clinical-stage company focused on the discovery and development of innovative small molecules for the treatment of autoimmune diseases, …See details»
Kangpu Announces First Patient Dosed in the US Phase IIa
SHANGHAI, June 12, 2022 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced today that the first patient has been dosed in …See details»
Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of …
SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced that, after consulting with the U.S. Food and …See details»
Our Culture-Kangpu Biopharmaceuticals - KangpuGroup.com
868 Sichuan Road, Suite 401, Building B1, Yungu Innovation Park, Baohe District, Hefei, Anhui Province, China. Email: [email protected]See details»
Kangpu Announces First Patient Dosed in the US Phase IIa Clinical …
SHANGHAI, June 13, 2022 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based in Shanghai, China, announced today that the first patient has been dosed in …See details»